Technical Analysis for TYME - Tyme Technologies, Inc.

Grade Last Price % Change Price Change
grade F 2.06 -8.85% -0.20
TYME closed down 8.85 percent on Friday, March 22, 2019, on 45 percent of normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Down Down
See historical TYME trend table...

Date Alert Name Type % Chg
Mar 22 Down 3 Days in a Row Weakness 0.00%
Mar 22 Down 4 Days in a Row Weakness 0.00%
Mar 21 Wide Bands Range Expansion -8.85%
Mar 21 Down 3 Days in a Row Weakness -8.85%
Mar 20 Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -9.65%
Mar 20 Narrow Range Bar Range Contraction -9.65%
Mar 20 NR7 Range Contraction -9.65%
Mar 20 Wide Bands Range Expansion -9.65%
Mar 19 Outside Day Range Expansion -10.04%
Mar 19 Wide Bands Range Expansion -10.04%

Older signals for TYME ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Tyme Technologies, Inc., formerly Global Group Enterprises Corp., conducts majority of its research and development activities and other business operations, through its subsidiary, Tyme Inc. (Tyme). Tyme is a clinical-stage biopharmaceutical company. Tyme is focused on the development and commercialization of highly targeted cancer therapeutics with a range of oncology indications. The Company's another subsidiary, Luminant Biosciences, LLC, conducts the initial research and development of the Company's therapeutic platform. The Company is formulating its regulatory and drug development program for its lead drug candidate, SM-88, and working towards the initiation of its Phase II clinical trial. The Company is also evaluating the expansion of its Phase II program to other types of cancer. The Company has not generated any revenue.
Biopharmaceutical Cancer Life Sciences Drug Development Cancer Therapeutics Millennium Pharmaceuticals Takeda Pharmaceutical Company
Is TYME a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 4.64
52 Week Low 1.93
Average Volume 767,418
200-Day Moving Average 2.7716
50-Day Moving Average 2.6134
20-Day Moving Average 2.31
10-Day Moving Average 2.238
Average True Range 0.2004
ADX 17.99
+DI 15.4329
-DI 26.8846
Chandelier Exit (Long, 3 ATRs ) 2.5788
Chandelier Exit (Short, 3 ATRs ) 2.6012
Upper Bollinger Band 2.6407
Lower Bollinger Band 1.9793
Percent B (%b) 0.12
BandWidth 28.632035
MACD Line -0.1469
MACD Signal Line -0.1527
MACD Histogram 0.0058
Fundamentals Value
Market Cap 184 Million
Num Shares 89.3 Million
EPS -0.14
Price-to-Earnings (P/E) Ratio -14.71
Price-to-Sales 0.00
Price-to-Book 0.00
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 2.42
Resistance 3 (R3) 2.45 2.36 2.36
Resistance 2 (R2) 2.36 2.27 2.35 2.34
Resistance 1 (R1) 2.21 2.21 2.17 2.18 2.32
Pivot Point 2.12 2.12 2.10 2.11 2.12
Support 1 (S1) 1.97 2.03 1.93 1.94 1.80
Support 2 (S2) 1.88 1.97 1.87 1.78
Support 3 (S3) 1.73 1.88 1.76
Support 4 (S4) 1.70